Is a pharmaceutical company that manufactures and supplies active pharmaceutical ingredients and other pharmaceutical products.
1984
India
1,001 - 5,000 employees
Pharmaceuticals
$100M - 500M in revenue
$25M - 100M in profitability
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.2
▼ 5.3%
0.2
▼ 6.8%
0.2
▲ 14.7%
34.6
2029Not available
Not available
Not available
Not available
5 out of 13 incl. management
| Target | Status | Temperature alignment | Year |
|---|---|---|---|
| Near-term target | Targets set | 1.5°C | FY2034 |
| Long-term target | Targets set | 1.5°C | FY2050 |
| Net-zero | Targets set | - | 2050 |
| Business Ambition 1.5°C | Not disclosed | - | - |
Overall Net-Zero Target: Neuland Laboratories Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Neuland Laboratories Limited commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by FY2034 from a FY2024 base year*. Neuland Laboratories Limited also commits to reduce scope 3 GHG emissions 63.8% per ton of product manufactured within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Neuland laboratories Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2024 base year. Neuland laboratories Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe.
Powered by illuminem and Science Based Targets initiative. Last updated: 31 Jul 2025| Target | Year | Value | Scope | Baseline |
|---|
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Climate Score
B
Water Score
A-
A
A-
B
B-
C
C-
D
D-